Secondary and Tertiary Poisoning Risks Associated
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Cómo Citar El Artículo Número Completo Más Información Del
Acta Pediátrica de México ISSN: 0186-2391 ISSN: 2395-8235 [email protected] Instituto Nacional de Pediatría México Avilés-Martínez, Karla Isis; Villalobos-Lizardi, José Carlos; López-Enríquez, Adriana Venta clandestina de rodenticidas, un problema de salud pública. Reporte de dos casos Acta Pediátrica de México, vol. 40, núm. 2, 2019, pp. 71-84 Instituto Nacional de Pediatría México Disponible en: https://www.redalyc.org/articulo.oa?id=423665708004 Cómo citar el artículo Número completo Sistema de Información Científica Redalyc Más información del artículo Red de Revistas Científicas de América Latina y el Caribe, España y Portugal Página de la revista en redalyc.org Proyecto académico sin fines de lucro, desarrollado bajo la iniciativa de acceso abierto CASO CLÍNICO DE INTERÉS ESPECIAL Acta Pediatr Mex. 2019 marzo-abril;40(2):71-84. Venta clandestina de rodenticidas, un problema de salud pública. Reporte de dos casos Clandestine sale of rodenticides, a health problem. Report of two cases Karla Isis Avilés-Martínez,1 José Carlos Villalobos-Lizardi,2 Adriana López-Enríquez3 Resumen ANTECEDENTES: La venta clandestina de rodenticidas es una manifestación de la pobreza y la exclusión social. Los rodenticidas adquiridos en estas circunstancias son accesibles porque tienen un canal de distribución eficiente. Su disponibilidad en casa, sin medidas de seguridad adecuadas y estrictas, representa un problema de salud potencialmente letal debido al contenido, falsificación, adulteración y etiquetado inadecuado o ausente. CASOS CLÍNICOS: Se reportan dos casos clínicos, no letales, de niños previamente sanos que ingirieron rodenticidas no etiquetados y obtenidos de la venta ilegal ambulante. El primer caso sufrió intoxicación por difetaliona (Clase Ia), rodenticida anticoagulante de segunda generación (en la bibliografía se reporta intoxicación en dos niños). -
“Baits and Baiting Strategies for Multi-Species Pest Control and Feral
Baits and baiting strategies for multi-species pest control and feral cats SCIENCE FOR CONSERVATION: 40 D.R. Morgan, J. Innes, C. Ryan, L. Meikle Published by Department of Conservation P.O. Box 10-420 Wellington, New Zealand 1 Science for Conservation presents the results of investigations contracted to science providers outside the Department of Conservation. Reports are subject to peer review within the Department and, in some instances, to a review from outside both the Department and the science providers. November 1996, Department of Conservation ISSN 1173-2946 ISBN 0-478-01855-X This publication originated from work done under Department of Conservation contract 1748 carried out by D.R. Morgan, J. Innes and C. Ryan, Manaaki Whenua – Landcare Research, P.O. Box 69, Lincoln; and contract 617, carried out by D.R. Morgan and L. Meikle, Manaaki Whenua – Landcare Research, P.O. box 31-011, Christchurch. It was approved for publication by the Director, Science and Research Division, Department of Conservation, Wellington. Cataloguing-in-Publication data Baits and baiting strategies for multi-species pest control and feral cats / D.R. Morgan ... {et al.} Wellington, N.Z. : Dept. of Conservation, 1996. 1 v. ; 30 cm. (Science for conservation, 1173-2946 ; 40.) Includes bibliographical references. ISBN 047801855X 1. Pests- -Control- -New Zealand. I. Morgan, D.R. (David Rowland), 1950- II. Series: Science for conservation (Wellington, N.Z.) ; 40. 632.9510993 20 zbn96-124202 2 CONTENTS PART 1: DEVELOPMENT OF MULTI-SPECIES BAITING (D.R. Morgan, J. Innes, C. Ryan) Abstract 5 1. Introduction 5 2. Background 6 3. Objectives 6 4. -
The Persistence and Secondary Poisoning Risks of Sodium Monofluoroacetate (1080), Brodifacoum, and Cholecalciferol in Possums
THE PERSISTENCE AND SECONDARY POISONING RISKS OF SODIUM MONOFLUOROACETATE (1080), BRODIFACOUM, AND CHOLECALCIFEROL IN POSSUMS C. T. EASON, G. R. WRIGHT, and L. MEIKLE, Manaaki Whenua - Landcare Research, P.O. Box 69, Lincoln, New Zealand. P. ELDER, Steroid and Immunobiochemistry Unit, Christchurch Health Laboratories, Christchurch Hospital, P.O. Box 151, Christchurch, New Zealand. ABSTRACT: To determine the risk of secondary poisoning for animals preying on sub-lethally poisoned brushtail possums, captive possums were treated with near-lethal doses of sodium monofluoroacetate (1080) or brodifacoum, and toxicant concentrations in blood and tissue were monitored over time. Sodium monofluoroacetate was rapidly eliminated from the blood (within three days). Brodifacoum was retained in the liver and, to a lesser extent, the muscle of possums for eight months after dosing. To determine the potential risk for animals scavenging on the carcasses of possums poisoned with cholecalciferol, cats were fed poisoned carcasses for six days. No changes in behavior, appetite, or body weight were observed. Serum calcium concentrations increased slightly, but remained within the normal range for cats. KEY WORDS: vertebrate pest control, secondary poisoning, sodium monofluoroacetate, brodifacown, cholecalciferol Proc. 17th Yertebr. Pest Conf. (R.M. Timm & A.C. Crabb, Eds.) Published at Univ. of Calif., Davis. 1996. INTRODUCTION 1995), and toxic amounts of brodifacoum may be retained Sodium monofluoroacetate (1080) has been used for in a carcass. vertebrate pest control in New Zealand since 1954. It is The existence of an effective antidote to brodifacoum currently used most frequently in aerially sown baits and in the form of vitamin Kl means that dogs that have eaten in baits in bait stations for the control of the Australian carcasses containing brodifacoum residues can usually be brushtail possum (Trichosurus vulpecula) (Livingstone saved. -
Pharmacokinetics of Anticoagulant Rodenticides in Target and Non-Target Organisms Katherine Horak U.S
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln USDA National Wildlife Research Center - Staff U.S. Department of Agriculture: Animal and Plant Publications Health Inspection Service 2018 Pharmacokinetics of Anticoagulant Rodenticides in Target and Non-target Organisms Katherine Horak U.S. Department of Agriculture, [email protected] Penny M. Fisher Landcare Research Brian M. Hopkins Landcare Research Follow this and additional works at: https://digitalcommons.unl.edu/icwdm_usdanwrc Part of the Life Sciences Commons Horak, Katherine; Fisher, Penny M.; and Hopkins, Brian M., "Pharmacokinetics of Anticoagulant Rodenticides in Target and Non- target Organisms" (2018). USDA National Wildlife Research Center - Staff Publications. 2091. https://digitalcommons.unl.edu/icwdm_usdanwrc/2091 This Article is brought to you for free and open access by the U.S. Department of Agriculture: Animal and Plant Health Inspection Service at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in USDA National Wildlife Research Center - Staff ubP lications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Chapter 4 Pharmacokinetics of Anticoagulant Rodenticides in Target and Non-target Organisms Katherine E. Horak, Penny M. Fisher, and Brian Hopkins 1 Introduction The concentration of a compound at the site of action is a determinant of its toxicity. This principle is affected by a variety of factors including the chemical properties of the compound (pKa, lipophilicity, molecular size), receptor binding affinity, route of exposure, and physiological properties of the organism. Many compounds have to undergo chemical changes, biotransformation, into more toxic or less toxic forms. Because of all of these variables, predicting toxic effects and performing risk assess- ments of compounds based solely on dose are less accurate than those that include data on absorption, distribution, metabolism (biotransformation), and excretion of the compound. -
Report on the Human Health Risk Assessment for the Lord Howe Island’S Proposed Rodent Eradication Program NSW Chief Scientist & Engineer
Report on the Human Health Risk Assessment for the Lord Howe Island’s proposed Rodent Eradication Program NSW Chief Scientist & Engineer July 2017 www.chiefscientist.nsw.gov.au/reports/independent-review-of-the-lord-howe-island-rodent- eradication-project The Hon. Gabrielle Upton MP Minister for the Environment Minister for Local Government Minister for Heritage 52 Martin Place SYDNEY NSW 2000 Dear Minister, Report – Independent Human Health Risk Assessment for the Lord Howe Island’s proposed Rodent Eradication Program In June 2016, your predecessor wrote requesting that I assist the Lord Howe Island Board in undertaking an independent Human Health Risk Assessment for the Lord Howe Island’s proposed Rodent Eradication Program in line with the Terms of Reference (see Appendix 1). As planned, an Expert Panel was convened and a suitable firm procured (Ramboll Environ Pty. Ltd.) to undertake the Human Health Risk Assessment, with input and review of the Expert Panel. The purpose of this report is to provide you with an overview of the process, the finding of the Human Health Risk Assessment and some observations and recommendations. The report of Ramboll’s is included as Appendix 2 of this report. I understand that the Human Health Risk Assessment is important for the Lord Howe Island community. During discussion between the Lord Howe Island Board (the Board) and my office, the Board has expressed an interest in representatives from the Expert Panel and the Office of the Chief Scientist & Engineer attending the island to participate in a community engagement event, discussing the outcomes of the Human health Risk Assessment. -
The Evaluation of Alternative Toxins to Sodium Monofluoroacetate (1080) for Possum Control
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by UNL | Libraries University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Proceedings of the Fifteenth Vertebrate Pest Vertebrate Pest Conference Proceedings Conference 1992 collection March 1992 THE EVALUATION OF ALTERNATIVE TOXINS TO SODIUM MONOFLUOROACETATE (1080) FOR POSSUM CONTROL Charles T. Eason Forest Research Institute, P.O. Box 31-011, Christchurch, New Zealand Follow this and additional works at: https://digitalcommons.unl.edu/vpc15 Part of the Environmental Health and Protection Commons Eason, Charles T., "THE EVALUATION OF ALTERNATIVE TOXINS TO SODIUM MONOFLUOROACETATE (1080) FOR POSSUM CONTROL" (1992). Proceedings of the Fifteenth Vertebrate Pest Conference 1992. 24. https://digitalcommons.unl.edu/vpc15/24 This Article is brought to you for free and open access by the Vertebrate Pest Conference Proceedings collection at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Proceedings of the Fifteenth Vertebrate Pest Conference 1992 by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. THE EVALUATION OF ALTERNATIVE TOXINS TO SODIUM MONOFLUOROACETATE (1080) FOR POSSUM CONTROL CHARLES T. EASON, Forest Research Institute, P.O. Box 31-011, Christchurch, New Zealand ABSTRACT: Possum control in New Zealand is dependent on the use of sodium monofluroacetate (1080) and cyanide. Although 1080 is highly effective, its use is restricted to government staff. Cyanide is available for a wider group of licensed operators, but cyanide "shyness" reduces its effectiveness. An acute toxicity programme has been set up to identify non- anticoagulant toxins that could be used safely by farmers. Dose-ranging studies showed that possums are susceptible to cholecalciferol, calciferol, gliftor, alpha-chloralose, and nicotine, but not to bromethalin. -
RRAC Guidelines on Anticoagulant Rodenticide Resistance Management Editor: Rodenticide Resistance Action Committee (RRAC) of Croplife International Aim
RRAC guidelines on Anticoagulant Rodenticide Resistance Management Editor: Rodenticide Resistance Action Committee (RRAC) of CropLife International Aim This document provides guidance to advisors, national authorities, professionals, practitioners and others on the nature of anticoagulant resistance in rodents, the identification of anticoagulant resistance, strategies for rodenticide application that will avoid the development of resistance and the management of resistance where it occurs. The Rodenticide Resistance Action Committee (RRAC) is a working group within the framework of CropLife International. Participating companies include: Bayer CropScience, BASF, LiphaTech S. A., PelGar, Rentokil Initial, Syngenta and Zapi. Senior technical specialists, with specific expertise in rodenticides, represent their companies on this committee. The RRAC is grateful to the following co-authors: Stefan Endepols, Alan Buckle, Charlie Eason, Hans-Joachim Pelz, Adrian Meyer, Philippe Berny, Kristof Baert and Colin Prescott. Photos provided by Stefan Endepols. Contents 1. Introduction ............................................................................................................................................................................................................. 2 2. Classification and history of rodenticide compounds ..............................................................................................3 3. Mode of action of anticoagulant rodenticides, resistance mechanisms, and resistance mutations ......................................................................................................6 -
Final Soft Bait Singapore Date Created: March 2017 Supplier: Bell Laboratories, Inc
FINAL®SOFT BAIT SAFETY DATA SHEET ACCORDING TO REGULATION: Section 274 of DATE OF ISSUE: PREPARED BY: the Work Health and Safety Act March 2017 CAR SECTION 1. PRODUCT AND COMPANY IDENTIFICATION Product Identifier: FINAL® SOFT BAIT Relevant identified uses: Anticoagulant Rodenticide - Ready to use Uses advised against: Use only for the purpose described above MANUFACTURER: IMPORTER: EMERGENCY PHONE NUMBERS: Bell Laboratories, Inc. Bentz Jaz Singapore Pte Ltd Consult the local/regional poison control 3699 Kinsman Blvd. 48 Toh Guan Road East, center. Madison, WI 53704, USA Enterprise Hub #06-139 email: [email protected] Singapore 608586 t +65 6841 2986 I f +65 6841 2026 www.bentzjaz.com.sg SECTION 2. HAZARDS IDENTIFICATION THIS PRODUCT IS CLASSIFIED AS: NOT HAZARDOUS ACCORDING TO THE CRITERIA OF SWA. NOT A DANGEROUS GOOD ACCORDING TO AUSTRALIAN DANGEROUS GOODS (ADG) CODE, IATA OR IMDG/IMSBC CRITERIA. SUSMP Classification: S6 ADG Classification: None allocated. Not a Dangerous Good according to Australian Dangerous Goods (ADG) Code, IATA or IMDG/IMSBC criteria. UN Number: None allocated GHS Signal word: WARNING HAZARD STATEMENT: H373: May cause damage to organs through prolonged or repeated exposure. PREVENTION P102: Keep out of reach of children. P264: Wash contacted areas thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P273: Avoid release to the environment. RESPONSE P313: Get medical attention/advice P321: Treatment with Vitamin K, which is antidotal, is almost always successful P337: If eye irritation persists: seek medical attention P353: Rinse skin or shower with water. P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. -
Secondary Poisoning of Foxes and Buzzards
Pergamon Chemosphere, Vol. 35, No. 8, pp. 1817-1829, 1997 © 1997 Elsevier Science Ltd All rights reserved. Printed in Great Britain PII: S0045-6535(97)00242-7 0045-6535197 $17.00+0.00 FIELD EVIDENCE OF SECONDARY POISONING OF FOXES (Vulpes vulpes) AND BUZZARDS (Buteo buteo) BY BROMADIOLONE, A 4-YEAR SURVEY Philippe J. Berny*, Thierry Buronfosse*, Florence Buronfosse**, Franqois Lamarque °and Guy Lorgue* * D6pt.SBFA - Laboratoire de Toxicologie - ENVL - BP-83 - 69280 Marcy l'Etoile (France) ** CNITV - ENVL - BP-83 - 69280 Marcy l'Etoile (France) ° ONC - Domaine de St Benotst - 78160 Auffargis (France) (Received in USA 17 February 1997; accepted 21 March 1997) Abstract This paper presents the result of a 4 year survey in France (1991-1994) based on the activity of a wildlife disease surveillance network (SAGIR). The purpose of this study was to evaluate the detrimental effects of anticoagulant (Ac) rodenticides in non-target wild animals. Ac poisoning accounted for a very limited number of the identified causes of death (1-3%) in most species. Predators (mainly foxes and buzzards) were potentially exposed to anticoagulant compounds (especially bromadiolone) via contaminated prey in some instances. The liver concentrations of bromadiolone residues were elevated and species-specific diagnostic values were determined. These values were quite similar to those reported in the litterature when secondary anticoagulant poisoning was experimentally assessed. ©1997 Elsevier Science Ltd Introduction This study reports anticoagulant (Ac) poisoning in wildlife. The Toxicology Laboratory of the Veterinary school in Lyon is involved in a unique nation-wide network for wildlife diseases surveillance (see material and methods). Ac poisoning is seldom described or investigated in wild animals, despite extensive use of rodenticides in the fields. -
Bromethalin: Secondary Toxicity
TECHNICAL BULLETIN RODENTICIDES BROMETHALIN: SECONDARY TOXICITY PRODUCT SCOPE Secondary toxicity of Bromethalin, the active ingredient in Fastrac and Talpirid Mole Bait. SECONDARY TOXICITY Bromethalin exerts its primary toxicity after conversion to the toxic metabolite, desbromethalin, which prevents cells from converting food into energy, leading to swelling of nerve cells, increased cerebrospinal pressure, and lethal disruption of the nervous system. In general, secondary toxicity occurs when an animal ingests a poisoned animal and then itself is impacted by the poison. The risk of secondary poisoning is aected by many factors: the sensitivity of the secondary consumer to the active ingredient, the amount and timing of rodenticide ingestion by the primary consumer, and the length of time the rodenticide remainsINSERT in the rodent TITLE tissue. LABORATORY STUDIES AND ANALYSIS OF WILDLIFE EXPOSURES Laboratory studies that involve feeding tissue from poisoned rodents to non-target animals and information from wildlife exposures are used to help assess secondary risk; however, the amount of data available for bromethalin is limited. In a secondary toxicity study in dogs conducted by an independent laboratory, daily feeding for two weeks with tissue from rats that were killed with 0.005% bromethalin showed no evidence of toxicity. PREVENTION As of 2018, to the best of our knowledge, there have been no reported cases of secondary poisoning from bromethalin rodenticides. However, rodenticide labels contain standard warning language to alert the user to the potential for unknown secondary toxicity risks. Pest control operators can reduce the risk for secondary poisoning in non-target animals by employing least hazardous methods and adhering to the label restrictions when using rodenticides. -
Successful Reversal of Anticoagulant Effect of Brodifacoum Poisoning with 4-Factor Prothrombin Complex Concentrate (PCC4)
Open Access Austin Journal of Pharmacology and Therapeutics Case Report Successful Reversal of Anticoagulant Effect of Brodifacoum Poisoning with 4-Factor Prothrombin Complex Concentrate (PCC4) Kusmierski KA*, Lackie CL and Scull JR Department of Pharmacy, Millard Fillmore Suburban Abstract Hospital, USA Title: Successful reversal of anticoagulant effect of brodifacoum poisoning *Corresponding author: Kusmierski KA, Department with 4-factor prothrombin complex concentrate (PCC4). of Pharmacy, Millard Fillmore Suburban Hospital, USA Introduction: Brodifacoum is a long-acting anticoagulant rodenticide that Received: March 17, 2017; Accepted: April 05, 2017; is similar to warfarin, but significantly more potent with prolonged half-life and Published: April 11, 2017 potential for severe coagulopathy. Case: A 43-year-old woman presented to the emergency department with non-traumatic bruising, abdominal pain, and hematuria. Initial evaluation revealed a severe coagulopathy and international normalized ratio (INR) greater than 13. PCC4 (Kcentra®) 25units/kg, phytonadione, and fresh frozen plasma (FFP) were administered with improvement in INR without additional intervention to control bleeding. A rebound increase in INR occurred within 24 hours. Brodifacoum toxicity was confirmed (brodifacoum level=300ng/mL) after patient admitted to possible cutaneous and aerosolized exposure to “rat poison.” The patient required FFP and high doses of phytonadione to control coagulopathy throughout her admission. She was discharged on phytonadione. Discussion: PCC4 administration improved coagulation parameters rapidly with control of bleeding and no adverse effects. The rebound in coagulation parameters demonstrated the continued need for treatment of coagulopathy while awaiting confirmation of brodifacoum poisoning. Conclusion: This case illustrates successful acute reversal of brodifacoum poisoning with Kcentra®, phytonadione, and FFP. -
Brodifacoum Coagulopathy from Tainted Synthetic Cannabinoids
SMGr up Case Report SM Journal of Brodifacoum Coagulopathy from Clinical Medicine Tainted Synthetic Cannabinoids James Granfortuna* Department of Hematology and Oncology, Cone Health teaching affiliate UNC Chapel Hill Medical Center, USA Article Information Abstract Received date: Nov 03, 2018 A recent cluster of patients presenting with idiopathic, severe, coagulopathy was reported in Illinois and Accepted date: Nov 16, 2018 traced to contaminated cannabinoids. The contaminating substance was determined to be brodifacoum, a potent, long acting, rodenticide that inhibits vitamin K dependent clotting factor production. Since the original reports from Published date: Nov 19, 2018 the Midwest, multiple additional cases have been reported in at least 11 states. Brodifacoum toxicity has now reached the proportions of a public health crisis. Patients can present with bruising, epistaxis, oropharyngeal and *Corresponding author gum bleeding, excessive menstrual bleeding, hematemesis, hematuria, flank pain, or abdominal pain mimicking an acute abdomen. We present a case of brodifacoum toxicity that was rapidly reversed with parenteral Vitamin James Granfortuna, Department of K and K-centra, four factor clotting concentrate. The use of intermittent prothrombin complex concentrates has Hematology and Oncology, Cone the ability to control life threatening hemorrhage and is a potential important adjunctive treatment to minimize Health teaching affiliate UNC Chapel use of large doses of vitamin K. Hill Medical Center, 1200 N Elm St, Greensboro, NC 27401, USA, Case Report Tel: 336-312-4050; Email: james. Case history [email protected] Distributed under Creative Commons A 54 year old male in good health except for treated hypertension and remote history of CC-BY 4.0 nephrolithiasis.